FDA Inspection
King Pharmaceuticals LLCKing Pharmaceuticals LLC – FDA Inspection, Jun 15, 2012
Record Details
This FDA Inspection record concerns King Pharmaceuticals LLC, with an inspection on June 15, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- King Pharmaceuticals LLC
- Inspection Date
- June 15, 2012
- Product Type
- Drugs
View Company Profile
ID · 4c1de0ec-f665-43b9-ae67-4c0c3cbe8959
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 786574
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.111Establishment of time limitations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of King Pharmaceuticals LLC
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2025 | OAI | Detroit District Office | Drug Quality Assurance |
| October 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for King Pharmaceuticals LLC
- FDA Inspection 1261579 - 2025-02-18
- FDA Inspection 1107986 - 2019-10-21
- FDA Inspection 1049269 - 2018-03-14
- FDA Inspection 1000037 - 2016-11-21
- FDA Inspection 926523 - 2015-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.